Advanced diagnostic approaches for feline IBD including endoscopy, biopsy, and biomarker testing enable more targeted treatment and better welfare outcomes.
Advanced diagnosis of feline IBD requires invasive procedures that cause short-term welfare costs but enable targeted treatment that provides long-term welfare benefit. The welfare cost of endoscopy under anaesthesia is small compared to the benefit of avoiding months of empirical treatment that may be ineffective. Accurate subtype diagnosis enables the most appropriate treatment selection from the first treatment choice.